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Abstract: The race for the next generation of painless and reliable glucose monitoring for 
diabetes mellitus is on. As technology advances, both diagnostic techniques and equipment 
improve. This review describes the main technologies currently being explored for noninvasive 
glucose monitoring. The principle of each technology is mentioned; its advantages and limitations 
are then discussed. The general description and the corresponding results for each device are 
illustrated, as well as the current status of the device and the manufacturer; internet references 
for the devices are listed where appropriate. Ten technologies and eleven potential devices are 
included in this review. Near infrared spectroscopy has become a promising technology, among 
others, for blood glucose monitoring. Although some reviews have been published already, 
the rapid development of technologies and information makes constant updating mandatory. 
While advances have been made, the reliability and the calibration of noninvasive instruments 
could still be improved, and more studies carried out under different physiological conditions 
of metabolism, bodily fluid circulation, and blood components are needed.
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Introduction
Diabetes mellitus (DM) is a major cause of mortality and morbidity in every  country. 
In 2011, more than 366 million people had DM worldwide.1 Due to the world’s increas-
ingly aging populations, increasingly unhealthy diets, sedentary lifestyles, and obesity, 
it is estimated that the prevalence of DM will increase to 552 million people by 2030.1 
DM is an intractable condition in which blood glucose levels  cannot be regulated nor-
mally by the body alone; it has many complications, including  cardiovascular  diseases, 
nephropathy, neuropathy, retinopathy, and amputations.2 The treatment methods include 
dietary regulation to control blood glucose levels, oral medication, and insulin injection; 
however, all of these have adverse effects on the patient’s quality of life.
Type 1 diabetes, Type 2 diabetes, and gestational diabetes are three main types of dia-
betes, although there are some other forms of DM, including congenital  diabetes, cystic 
fibrosis-related diabetes, and steroid diabetes, induced by high doses of  glucocorticoids.3 
Type 1 diabetes is an autoimmune disease with pancreatic islet beta cell destruction. It 
is an autoimmune disorder in which the body cannot produce sufficient insulin. Type 2 
diabetes, the most prevalent form, results from insulin resistance with an insulin secre-
tary defect. Both Type 1 and Type 2 diabetes are chronic c onditions that usually cannot 
be cured easily. Gestational diabetes is the term used when a woman develops diabetes 
during pregnancy. Generally, it resolves after delivery, but it may precede development 
of Type 2 diabetes later in life.
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The control of blood glucose levels relies on blood 
glucose measurement. Diabetic patients, whether Type 1 or 
Type 2, are encouraged to check their blood glucose levels 
several times per day; currently, the most common means 
of checking is by using a finger-prick glucose meter.4 In this 
way, diabetic patients can obtain a clear picture of their blood 
glucose levels for therapy optimization and for insulin dosage 
adjustment for those who need daily injections.
Finger-pricking, however, has several disadvantages. 
Many people dislike using sharp objects and seeing blood, 
there is a risk of infection, and, over the long term, this 
practice can result in damage to the finger tissue. Given these 
realities, the advantages of a noninvasive technology are 
easily understood. Further, the finger-prick glucose meter is a 
discrete glucose measurement device that is not practical for 
continuous monitoring of blood glucose. Some incidences of 
hyperglycemia or hypoglycemia between measurements may 
not be recorded. Thus, the resultant monitoring cannot fully 
represent the blood glucose pattern. Noninvasive glucose 
measurement eliminates the painful pricking experience, 
risk of infection, and damage to finger tissue.
The noninvasive concept was launched more than 
30 years ago. Nevertheless, it can be said that most of the 
noninvasive technologies are still in their early stages of 
development. Many noninvasive technologies have been 
described in the literature, and there is an increasing vol-
ume of recent research results. Keeping up with the cur-
rent situation requires constant updating.5 The results of 
an Internet search provide much information on this topic, 
such as overviews of noninvasive technology,6 the future 
development of meters and monitors for diabetes,7 and 
information about research centers that are developing this 
technique;”8 however, the scope of devices is so broad that 
no single site can keep up. As a result, much of the infor-
mation is outdated.9 Therefore, the aim of this review is to 
present the current state of noninvasive glucose monitoring 
for diabetes. It will describe the technologies being used, 
technologies in development, devices being used, and the 
companies producing these devices. Websites will be men-
tioned as appropriate.
Noninvasive glucose-monitoring 
technologies
In this review, we consider noninvasive glucose measurement 
as any technique that does not involve pricking (breaking) 
the skin. The different techniques/technologies are listed 
in alphabetical order. The principles of each technology, 
together with its advantages and limitations, are discussed.
Bioimpedance spectroscopy
Principles
Bioimpedance is a measure of the resistance to electric 
 current flowing through the tissues of a living organism. 
The measurement of bioelectrical impedance has proved 
useful as a noninvasive method for measuring body 
 composition.10 The impedance spectrum, or dielectric spec-
trum, is measured in the frequency range of 0.1 to 100 MHz. 
 According to Hillier et al,11 variations in plasma glucose con-
centration induce, in red blood cells, a decrease in sodium ion 
concentration and an increase in potassium ion concentration. 
These variations cause changes in the membrane potential of 
red blood cells, which can be estimated by determining the 
permittivity and conductivity of the cell membrane through 
the dielectric spectrum.12–14 In 2003, the company Pendragon 
Medical Ltd. (Zurich, Switzerland) developed a wrist-band-
based glucose monitor called “Pendra.” However, this product 
was soon withdrawn from the market because of poor reli-
ability. Caduff et al are still working on this technology.15
Advantages
Bioimpedance spectroscopy does not require the use of 
statistically-derived, population- specific prediction models. 
It has the potential advantage of being able to differentiate 
between extracellular water and intracellular water and, thus, 
to provide an estimate of body cell mass, thus characterizing 
the blood bioimpedance properties. The instrument is easy 
to use and low in cost compared to other devices.
Limitations
The limitation of this technology is that it requires an equili-
bration process, wherein the user must rest for 60 minutes 
before starting the measurements.12 Moreover, some problems 
remain to be resolved, such as the effects of temperature 
and body water content (eg, skin moisture, sweat, overall 
 hydration) on readings.15
Electromagnetic sensing
Principles
Similar to bioimpedance spectroscopy, this technology 
assesses dielectric parameters of blood. The difference 
between them is that an electric current is used in bioimped-
ance spectroscopy, while the electromagnetic coupling 
between two inductors is used in electromagnetic sensing.16,17 
The sensor uses electric currents to detect variation of the 
dielectric parameters of the blood, which may be caused by 
glucose concentration changes.18 The frequency range used 
in this technique is 2.4–2.9 MHz. However, depending on the 
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temperature of the investigated medium, there is an optimal 
frequency, where sensitivity to glucose changes reaches its 
maximum. Determining this frequency is important for the 
efficacy of the device. Gourzi et al suggested the optimal 
frequency is 2.664 MHz at 24°C.16 However, another study 
of this technology, using pig blood, suggests that the optimal 
operating frequency is 7.77 GHz at 25°C.19
Advantages
Using a specific frequency range can isolate the effect of 
blood glucose and minimize the characteristics of other 
substances, such as cholesterol, which might skew  readings. 
In addition, it is relatively safe, as it will not ionize the 
 molecules of the body.
Limitations
Temperature has a strong effect on this form of measurement, 
because it influences the optimal investigation frequency. 
Furthermore, Moran et al reported that the blood  dielectric 
parameters depend on several components other than 
 glucose.18 Therefore, more study of potential confounders is 
needed before this technology can be considered reliable.
Fluorescence technology
Principles
This technique uses fluorescence reagents to track the 
presence of glucose molecules in blood. Many approaches 
exist, such as measuring changes in fluorescence resonance 
energy transfer between a fluorescent donor and an acceptor, 
or measuring glucose-induced changes in intrinsic fluores-
cence of enzymes.20 One study reported that glucose levels 
in tears reflect concentrations similar to those in blood, 
and thus, fluorescence of tears can be used as noninvasive 
glucose monitoring. Khalil reported that this approach can 
track blood glucose with an approximate 30-minute lag time 
and does not suffer from interference from variations in the 
light intensity of the ambient environment.21 The photonic 
sensing is achieved with polymerized crystalline colloidal 
arrays, which respond to different concentrations through 
diffraction of visible light.
Advantages
This technology is very sensitive; it can detect single 
 molecules. It causes little or no damage to the body. 
In  addition, it can give results in terms of fluorescence inten-
sity and decay times, both of which are independent of light 
scattering and fluorophore concentration, which can reduce 
loss through diffusion or degradation.
Limitations
Photonic sensing can suffer from strong scattering phenom-
ena, especially in fluorescence technology. Moreover, there 
are limitations, such as short lifetimes and biocompatibility, 
which need to be dealt with, possibly through the use of 
colorimetric assays.22
Mid-infrared spectroscopy
Principles
Mid-infrared (MIR) spectroscopy employs the same prin-
ciples as infrared spectroscopy; in other words, it is the 
absorption measurement of MIR frequency by a sample 
positioned in the path of an MIR beam. It is based on light 
in the 2500–25,000 nm region of the spectrum.  Absorption 
d ifferences when MIR light meets human tissues can be 
represented by certain modeling techniques in spectral 
quantitative analysis. A partial least squares algorithm is 
now normally used for multivariate calibration for these 
constituents.
Advantages
MIR exhibits decreased scattering phenomena, yet increased 
absorption, because of the higher wavelengths compared with 
near infrared (NIR) spectroscopy.23 Light can penetrate skin 
to a depth of a few micrometers. As a result, only reflected 
light can be considered, because there is no light transmit-
ted through a body segment. Moreover, another possible 
advantage of MIR spectroscopy is that the response peaks 
of glucose and other compounds are sharper with MIR than 
with NIR, where they are often broad and weak.
Limitations
Poor penetration is the main limitation of MIR. Other 
limitations, as with NIR, include problems with confounding 
 factors, such as water content in blood.24
Near infrared spectroscopy
Principles
Near infrared (NIR) spectroscopy is located in the wavelength 
region of 730–2500 nm. The principle is similar to that of 
MIR spectroscopy. NIR spectra are made up of broad bands 
corresponding to overlapping peaks: the overtones (ie, first, 
second, third, and combination overtones), formed by 
molecular vibrations. It allows blood glucose measurement 
in tissues by variations of light intensity, based on 
transmittance and reflectance. Heise et al, one of the pioneers 
in noninvasive blood glucose monitoring, has published much 
on NIR techniques.25–27 Raghavachari reported that glucose 
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generates one of the weakest NIR absorption signals per 
concentration unit of the body’s major components.28 Maruo 
et al demonstrated the efficacy of this approach in vivo, using 
NIR diffuse reflectance spectroscopy through fiber optics on 
diabetes patients’ forearms.29 The results showed positive 
signs on the correlation between predicted values and the 
reference glucose levels. Arnold and Small also reported 
that, although measurement errors of NIR spectroscopy are 
too large for clinical purposes, these experimental results 
demonstrate the possibility of noninvasive blood glucose 
measurements.30
Advantages
The high sensitivity of the photoconductive detectors is the 
main advantage of NIR spectroscopy. Water is reasonably 
transparent to the signal bandwidth used by NIR, which 
makes it possible to use for blood glucose monitoring. In 
addition, the measuring signal has high energy compared 
with MIR spectroscopy. Perhaps even more important, this 
method is less expensive than MIR. Materials are rela-
tively low in cost, and there is a wide range of commercial 
 products available. These advantages make NIR popular in 
this research area.
Limitations
Despite much promising work, researchers still cannot 
overcome important shortcomings, in particular, the scan-
ning pressure that must be applied, physiological differences 
not related to blood glucose, the relatively small fraction of 
glucose in blood, weak correlation, and hardware sensitivity 
and stability.
Optical coherence tomography
Principles
Optical coherence tomography is an optical signal 
 acquisition method based on the use of a low coherence 
light, such as a super luminescent light, an interferometer 
with a reference arm and a sample arm, a moving mirror 
in the reference arm, and a photodetector to measure the 
 interferometric signal.31 Light backscattered from tissues is 
combined with light returned from the reference arm of the 
 interferometer, and the  resulting interferometric signal is 
detected by the  photodetector. The delay correlation between 
the  backscattered light in the sample arm and the reflected 
light in the reference arm is measured. An increase of  glucose 
concentration in the interstitial fluid causes an increase in 
refractive index, which in turn creates a decrease in the mis-
match between sample and reference indices.
Advantages
This technology provides advantages in signal to noise ratio, 
high resolution, and depth of penetration, because the inter-
ferometric signal can be formed only within the coherence 
length of the source.
Limitations
Optical coherence tomography may be sensitive to the 
individual’s motions. In addition, although slight changes 
in skin temperature have negligible effects, changes of 
several degrees have a significant influence on the signal.32 
Furthermore, there is no clear evidence that this method has 
advantages compared to other scattering-based techniques.
Optical polarimetry
Principles
Some researchers are trying to apply optical polarimetry in 
noninvasive glucose monitoring. Because the high scattering 
coefficients produce complete depolarization when the beam 
strikes the skin, attention has been focused on the eye, which 
offers a clear optical medium with a reasonable path length in 
relation to blood glucose.33 When light transverses vitreous 
humor, it is expected to rotate several degrees in relation to 
the concentration of glucose.
Advantages
As light absorption and scattering in the eye are low, and there 
are virtually no large proteins in the aqueous humor, the main 
component in the aqueous humor is glucose; therefore, 
 correlation may exist and relate to determine blood glucose 
 concentration. In addition, this technique makes use of visible 
light, and the optical components can easily be miniaturized.
Limitations
This technique is sensitive to the scattering properties of 
the investigated tissue, as scattering depolarizes light. As a 
result, skin cannot be investigated by polarization technol-
ogy, because it shows a high scattering effect, particularly 
in the stratum corneum. In addition, eye movement and 
motion artifact are general sources of errors in this tech-
nique.  Furthermore, the specificity of this technique is poor, 
as  several optically active compounds are present in human 
fluids containing glucose, such as albumin and cholesterol.
Raman spectroscopy
Principles
Raman spectroscopy is based on the use of a laser light to 
induce oscillation and rotation in human fluids containing 
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glucose. Because the emission of scattered light is influenced 
by molecular vibration, it is possible to estimate glucose 
concentration in human fluids.34
This effect depends on the concentration of the glucose 
molecules. This technique can measure very weak signals, 
even in human fluids. The wavelength range of Raman spec-
trum is considered to be 200 cm−1 to 2,000 cm−1.35 Raman 
spectrum of glucose can be differentiated from those of other 
compounds in this band.
Advantages
Raman spectroscopy usually provides sharper and less over-
lapped spectra compared to NIR spectroscopy. The intensity 
of spectral features is proportional to the concentration of 
the particular species, and the spectra are less sensitive to 
temperature changes. Moreover, it is comparatively less 
sensitive to water, and the interference from luminescence 
and fluorescence phenomena is only modest.
Limitations
The main limitations are related to instability of the laser 
wavelength and intensity, and long spectral acquisition times. 
In addition, as the power of the light source must be kept 
low to prevent injury, the signal-to-noise ratio is significantly 
reduced. Moreover, as with NIR spectroscopy, interference 
from other compounds remains a problem.
Reverse iontophoresis
Principles
Reverse iontophoresis is based on the flow of a low electri-
cal current through the skin, between an anode and cathode 
positioned on the skin surface. An electric potential is applied 
between the anode and cathode, thus causing the migration 
of sodium and chloride ions from beneath the skin toward the 
cathode and anode, respectively. In particular, it is sodium 
ion migration that mainly generates the current.36 This mea-
surement is possible because neutral molecules, such as 
glucose, are extracted through the epidermis surface during 
this convective flow. This flow causes interstitial glucose to 
be transported, collecting at the cathode, where a traditional 
glucose sensor is placed to measure glucose concentration 
directly. The “GlucoWatch” device (Cygnus Inc., Redwood 
City, CA) is based on this technology, and it was approved by 
the US Food and Drug Administration. The device collects 
glucose molecules through the cathode disk and measures the 
amount with a sensor that contains enzyme glucose oxidase. 
Blood glucose concentration is predicted by comparing the 
premeasured blood glucose value with the signal generated 
by glucose molecules collected at the cathode. However, this 
product was withdrawn from the market due to poor accuracy, 
skin irritation, and long procedural problems.
Advantages
The advantage of this technology is that the electrodes are 
easily applied to the skin, by which a physiologically relevant 
fluid sample is collected, in that there is a correlation between 
glucose concentration in the physiological fluid and glucose 
concentration in blood.
Limitations
While reverse iontophoresis technology has great potential, the 
only device ever marketed using it had such serious practical 
drawbacks that it was withdrawn from the market. First, the 
electrodes irritated the skin. Second, the electrodes needed to 
be in place for at least 60 minutes, which exceeded the patience 
of many users. Third, readings were inaccurate, especially when 
the subject was sweating. Fourth, it was not able to detect rapid 
changes in blood glucose, due to its long “wakeup” time.
Ultrasound technology
Principles
Ultrasound technology is based on low-frequency ultra-
sound, which penetrates the skin for blood glucose monitor-
ing. While this approach has theoretical potential, it seems 
that no further works has been done since Lee’s group 
reported their laboratory results on rat skin.37 A variation, 
named photoacoustic spectroscopy, is being used, which is 
based on the use of a laser light for the excitation of a fluid 
and for measuring the resulting acoustic response.38 The 
fluid is excited by a short laser pulse with a wavelength that 
is absorbed by a particular molecular species in the fluid. 
Light absorption causes microscopic localized heating in 
the medium, which generates an ultrasound pressure wave 
that is detected by a microphone. The principle of the pho-
toacoustic method is that an energy source irradiates the 
skin surface, causing thermal expansion in the illuminated 
area. An acoustic wave releases because of the energy of 
the thermal expansion. The detection of glucose with this 
technique is based on measuring the changes of the peak-
to-peak value of the signal, which varies according to the 
glucose content of the blood.
Advantages
This technology can provide higher sensitivity than  traditional 
spectroscopy in the determination of glucose, because of the 
relatively better photoacoustic response of blood, as compared 
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with water. This makes it easier to distinguish hydrocarbons 
and glucose.37 In addition, the laser light wavelengths that can 
be used have a wide range, from ultraviolet to NIR.
Limitations
The technology is sensitive to interference from some bio-
logical compounds, temperature fluctuations, and pressure 
changes. Moreover, when the laser light transverses a dense 
medium, the photoacoustic signal may be affected by scatter-
ing phenomena, which may possibly cause an adverse effect 
similar to that of NIR spectroscopy. Another disadvantage is 
that the instrumentation is expensive and sensitive to envi-
ronmental parameters.
Challenges ahead for noninvasive 
glucose monitoring
Various noninvasive technologies have been discussed. 
Clearly, many research groups are exploring a wide variety of 
approaches, trying to develop a blood glucose measurement 
device that can provide stable and reliable results, conveniently 
and economically. Table 1 shows the most recent works and 
internet references. Discontinued products, such as Gluco-
Watch, Diasensor (Biocontrol Technology Inc., Pittsburgh, 
PA), and Pendra, are not listed.
It is worth noting that not much evidence has proven the 
analytical feasibility of glucose monitoring by the noninva-
sive devices listed in Table 1. The supporting documentation 
provided by the research groups is severely limited; most of 
the technologies are proprietary, and limited information is 
disclosed. Although some of the technologies are mentioned 
in the referred papers, very little specific relevant informa-
tion is provided. In particular, the judgments of measurement 
accuracy are completely left out.
At the same time, Table 1 tells us that many research 
groups are working on this problem, trying to develop new 
measurement technologies and methods to measure blood 
glucose noninvasively. One of the main reasons is that 
existing technologies, such as absorption spectroscopy, are 
relatively poor in signal-to-noise ratio in relation to blood 
glucose concentration and spectra response. Due to the huge 
Table 1 Information regarding noninvasive glucose monitoring devices
Device/company Technology Status URL
BioSensors Inc. SEMP technology 
(bioimpedance  
spectroscopy)
Appeared in 2010 and is under 
development
http://www.biosensors-tech.com/
ClearPath DS-120,  
Freedom Meditech
Fluorescent technology Appeared in 2007 and is said to be 
delivered to FDA for approval in 2011
http://freedom-meditech.com/
Cnoga Medical NIR spectroscopy Appeared in 2010 and is said to be 
delivered to FDA for approval in 2011
http://www.cnoga.com/Medical/Products/Glucometer.aspx
C8 MediSensors Raman spectroscopy Appeared in 2011 and the current  
status is investigational device
http://www.c8medisensors.com/us/home.html
Easy Check,  
Positive ID
Chemical sensing  
in exhaled breath
Appeared in 2010 and is under 
development
http://www.positiveidcorp.com/products_easycheck.html
EyeSense Fluorescent technology Appeared in 2008 and is still in  
R&D phase; plan is to launch  
the device in 2013
http://www.eyesense.com/en/konzept.htm
Glucoband,  
Calisto Medical Inc.
Bio-electromagnetic 
resonance
Appeared in 2005 and claimed  
under pilot production in 2011
http://www.calistomedical.com/
GlucoTrack,  
Integrity  
Applications Ltd.
Ultrasonic,  
conductivity  
and heat capacity  
technology
Under clinical trials phase  
(last checked: 2011)
http://www.integrity-app.com/
Glove Instruments NIR spectroscopy 
(optical bridge  
technology)
Appeared in 2008 and is said to be  
commercialized soon, in late 2011
http://groveinstruments.com/
OrSense Ltd. Occlusion technology 
(proprietary  
technology)
Appeared in 2006; the company  
has stated that this product is for  
market awareness purpose only
http://www.orsense.com/Glucose
SCOUT  
DS, veraLight Inc.
Fluorescent  
spectroscopy
Appeared in 2011 and has received  
approval from health Canada for  
commercial distribution
http://www.veralight.com/products.html
Abbreviations: NIR, near-infrared spectroscopy; ID, identification; R&D, research and development; FDA, Food and Drug Administration.
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anticipated market for a successful, noninvasive glucose 
monitoring device, the race for research teams to develop 
more precise and accurate spectroscopic equipment is heated. 
Moreover, multivariate training methods are often used in 
the quantitative analysis that the prediction model is data-
dependent, whereas the specificity of measurement is not 
easy to tackle. Although an improved method is investigated 
for quantitative analysis that can enhance the correlation of 
the spectroscopic properties of the glucose molecule with 
glucose concentration in blood, more effort should be made to 
rigorously extend the technique to noninvasive blood glucose 
monitoring.39
Moreover, calibration of spectroscopic devices is neces-
sary, because of factors such as light intensity, which may 
affect the prediction model. As most of the noninvasive 
technologies are based on some type of optical sensing 
technique, a time lag may occur between measurements of 
blood glucose content from different parts of body, which 
could introduce calibration error. In addition, the force of 
the measurement area may affect the deformation of the 
contact point of the tissue. This problem can be solved by 
applying constant force to the measurement area; however, 
it would be likely to produce a poor prediction result after a 
long period of time. This is because different deformations 
of the tissues may cause diverse absorption or reflection 
properties, thus affect the resulting signal. In addition, tem-
perature may affect the prediction result, particularly for opti-
cal sensing technology, because changes of several degrees 
may significantly influence the energy level of absorption 
content. Most importantly, the physiological effect of the 
human being is the most important factor in noninvasive 
glucose monitoring. Physiological differences would affect 
the reliability of different technologies, as they are mainly 
due to individual metabolism, blood components, and other 
bodily fluid circulations for body regulation. The absorp-
tion spectroscopy mainly detects the glucose molecule, and 
glucose can be found everywhere in the human body. Hence, 
it is difficult to have a universal prediction model instead of 
a single user prediction model, which may need frequent 
self-calibration.
Conclusion
In this review, the latest technologies and devices for noninva-
sive glucose monitoring have been described. Unfortunately, 
none of these technologies have produced a commercially 
available, clinically reliable device; therefore, much work 
remains to be done. It is relatively simple to measure data 
and find correlation with blood glucose levels under the 
controlled conditions of research laboratories: the challenge 
is measuring these variables in normal environments. This 
requires understanding the physical and physiological factors 
that may affect blood glucose measurement. It is important 
to notice that noninvasive monitoring will never be achieved 
without vigorous scientific and clinical evidence. At this 
stage, we are still far away from achieving the goal of nonin-
vasive blood glucose monitoring, with many technical issues 
yet to be resolved.
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